(Total Views: 601)
Posted On: 01/15/2019 1:42:02 PM
Post# of 83
IGXT = MC $49 M / $13 M Cash / FDA Decision for Migraine Drug on APRIL 1 / HOT Cannabis Play has Deal with TILRAY (TLRY) / UNDISCOVERED Stock = 500%++GEM LOAD UUP WHILE ITS STILL DIRT CHEAP and enjoy the FDA run up ..
IGXT announced that the FDA has accepted the resubmission of 505(b)(2) new drug application (NDA) for Rizaport oral soluble film 10 mg, which is being developed for the treatment of acute migraine. The FDA has set an action date of Apr 1, 2019.
IntelGenx: A Small Cap With A Big Pipeline In Cannabis, Alzheimer's, And ED
https://seekingalpha.com/article/4208382-inte...heimers-ed
Presentation
http://s2.q4cdn.com/790425727/files/doc_prese...tation.pdf
IGXT announced that the FDA has accepted the resubmission of 505(b)(2) new drug application (NDA) for Rizaport oral soluble film 10 mg, which is being developed for the treatment of acute migraine. The FDA has set an action date of Apr 1, 2019.
IntelGenx: A Small Cap With A Big Pipeline In Cannabis, Alzheimer's, And ED
https://seekingalpha.com/article/4208382-inte...heimers-ed
Presentation
http://s2.q4cdn.com/790425727/files/doc_prese...tation.pdf
(0)
(0)
